APPROXIMATELY one-third of patients with Felty's syndrome (FS: RA with idiopathic neutropenia) have clonal peripheral blood T-cell expansions of lymphocytes with a large granular morphology (LGLs) [1] . These expansions are typically CD3+ CD8 + and often express CD57. The function of CD57 is unknown, but it is likely to be an activation marker for at least a proportion of CD8 cells [2] . LGL levels are increased in chronic viral infections, such as cytomegalovirus and HIV, as well as in abnormal immunological situations such as post-splenectomy and following bone-marrow transplantation [1] . It is unclear in FS whether they have a pathological role and/or are markers for a specific viral infection or for immune dysfunction. One hypothesis, however, is that clonal peripheral blood LGL expansions in FS reflect chronic antigenic stimulation leading to low-grade 'malignant' transformation. If this were the case, then they might be expected to have the cell-surface phenotype of conventional activated T cells. In order to address this hypothesis, a cytofluorographic analysis of peripheral blood lymphocytes from such patients was performed using monoclonal antibodies directed against cell-surface markers of activation.
PATIENTS AND METHODS
Ten patients with rheumatoid arthritis (RA) (fulfilling the 1987 ARA criteria) and T-cell LGL expansions were studied. Eight had FS with a current or past history of unexplained neutropenia (neutrophil count of <2 x lCC/l) persisting for at least 6 months. Splenomegaly, although commonly found in FS and part of the original description, is no longer regarded as obligatory to make the diagnosis [3] . The LGL syndrome was defined as the presence of > 1 x 10 9 /l morphological LGLs in the peripheral blood or the same number of CD3+ CD57+ cells by cytofluorographic analysis, persisting for at least 6 months. Since lymphopenia can be present in the LGL syndrome, an alternative criterion was the presence of morphological
LGLs or CD3 + CD57 + cells comprising at least 25% of lymphocytes. Data are also reported on two patients with T-cell LGL expansions without RA and four patients with RA without LGL expansions or FS. All patients were North European caucasoids, except for one patient of Turkish-Cypriot origin.
Venous peripheral blood or synovial fluid was collected in preservative-free heparin and mononuclear cells separated on a Lymphoprep (Nycomed, Oslo, Norway) density gradient. Immunophenotyping was carried out as previously described with cytofluorography performed on a Beckton-Dickinson FACScan (Becton Dickinson, Oxford) [3] . Double staining was performed using phycoerythrin (PE) and fluorescein isothiocyanate (FITC) conjugated monoclonal antibodies. These included mouse IgGl antibodies as negative controls, anti-CD3, anti-CD4, anti-CD8, anti-CD57, anti-TcR aft and y/J, FTTC-conjugated goat anti-mouse, anti-HLA-DR, anti-CD25 (IL-2R 'Tac'), anti-CD69 (Leu-23), anti-Leu-8, anti-CD45RA, anti-CD45RO, all from Becton Dickinson, anti-CD45RB (PD7/26, a gift of Dr D. Mason, The John Radcliffe Hospital, Oxford), anti-CD54 (ICAM-1, 6.5B5, [4] ), anti-CD 11 a (LFA-1, American Type Culture Collection, Rockville, MD, USA), anti-CD49d (VLA-4, P4G9, [5] ). In some experiments, anti-ICAM-1 antibody 15/2 and anti-LFA-1 antibody m38 [6] , a gift of Dr C. Buckley (Institute for Molecular Medicine, Oxford), were used (see Table I ). W112 (anti-V05.3) [7] was a gift of Professor A. W. Boylston, St James University Hospital, Leeds.
RESULTS
The 10 RA patients with T-cell LGL expansions comprised six males and four females, with a mean age (±s.D.) of 70 ± 12 yr (range 49-83 yr). The mean duration of RA was 18 ± 15 yr (range 1-54 yr). All patients except one were rheumatoid factor positive, four were known to have splenomegaly and five were on prednisolone. Eight had FS with a mean duration (±s.D.) of 4.1 ±4.8yr (range 0.5-14 yr). The mean current lymphocyte count was 4.9 ± 3.7 x lO'/l (range 1.3-11.2 x 10'/l)and neutrophil count 1.7 ± 1.6 x 10 9 / 1 (range 0.3-2.0 x lO'/l, except for one patient whose neutrophil count had returned to normal at 5.4 x 10 9 / 1). Seven out of the eight with FS had evidence of clonal T-cell expansions by restriction fragment length polymorphism (RFLP) or T-cell receptor /3-chain sequencing analysis [3] . Two patients with T-cell LGL expansions without RA were studied. The first was a male aged 74 yr with a 4 yr history of idiopathic neutropenia and splenomegaly with a current lymphocyte count of 1.6 x lO'/l (patient 11). The second was a female aged 49 yr with splenomegaly and recurrent infections with a 16yr history of lymphocytosis and who had been treated in the past at various times with CHOP, cyclosporine and G-CSF (patient 12). Both had clonal T-cell LGL expansions by RFLP analysis (data not shown). Data from four female patients with seropositive erosive RA without FS are also reported.
Their mean age (±S.D.) was 64 ± 6 yr (range 58-71 yr) and duration of RA was 13.0 ± 5.7 yr (range 8-21 yr). All were on disease-modifying agents, but none were taking oral corticosteroids. Table I shows the results of the cytofluorographic analysis of the peripheral blood from all the patients studied and the synovial fluid from patient 8. In the seven patients with FS and clonal LGL expansions, the phenotype of the expansions was CD3 + , CD8 + , CD57 + , HLA-DR+ , CD25-, CD69 + , Leu-8-, CD45RA + , CD45RB""* 111 , CD45RO-, ICAM-1/ LFA-1/VLA-4 + . The peripheral blood from the three patients with RA, but without evidence of clonal LGL expansions by RFLP analysis, differed from this phenotype in unique ways. In patient 8 (with FS), the CD8+ cells were CD45RA-, CD45RB bd * ht , CD45RO + . In patient 9, the phenotype was CD25 + , Leu-8+ , and both CD45RA+ and CD45RO+ were expressed at a high level, suggesting simultaneous expression on 52.3-72.9% of the cells (CD45RB was not analysed). In patient 10, the expanded cells did not express HLA-DR. Only two patients with clonal T-cell LGL expansions without RA were available for study. Although the data are limited, the initial results suggest that T-cell LGL expansions in such patients have a similar cell surface phenotype to the group with FS and clonal T-cell LGL expansions. Compared to CD8 T-cells from the peripheral blood of RA patients, the FS patients' CD8 cells expressed higher levels of HLA-DR, CD45RA and ICAM-1, and lower levels of Leu-8 and CD45RO. 
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In patient 8, we were able to compare synovial fluid mononuclear cells from the left knee with those of peripheral blood (Table I) . This patient has an expansion of CD3+ CD8+ CD57+ cells in the peripheral blood with 90% of the CD8 cells expressing CD57 (normal range < 30%) (data not shown). T-cell clonality could not be demonstrated using RFLP analysis, although this does not fully exclude this possibility [3] . A total of 32.3% of peripheral blood CD8 cells expressed V/?5.3 (normal range in our laboratory 0.4-1.8%, data not shown). This patient's peripheral blood was also examined using seven other anti-V/? antibodies without finding any further expansions [3] . These V/?5.3 + cells were shown to be mostly CD45RA-, CD45RB brilht and CD45RO + . In the synovial fluid, CD57 and CD45RO expression on synovial fluid CD8 cells was also high (71.7 and 89.2%, respectively). The V/J5.3+ cells forming part of the expanded population in the peripheral blood were not, however, seen in the synovial fluid (V7?5.3/CD8 = 7.9%). The patient did not consent to synovial biopsy, so we were unable to examine the possibility that these cells entered the synovial membrane, but not the fluid. [8] . It has also been demonstrated in CD8+ T cells that CD45RA-, RO+ cells have a higher proportion of memory cytotoxic T-lymphocyte precursors [9] , and higher levels of proliferation and cytokine secretion [10] compared to CD45RA + , RO-, CD8+ T cells.
The starting point for this study was the hypothesis that clonal LGL expansions in FS reflected chronic antigenic stimulation and, hence, would have the phenotype of activated 'memory' cells. This was obviously not the case in terms of CD45 isoform expression in that the commonest phenotype was of CD45RA + , CD45RB brl « hl , CD45RO-cells. Other markers of activation, however, such as HLA-DR, LFA-1, ICAM-1 and VLA-4, were expressed by these T-cell expansions. CD25, which is only transiently expressed during activation, was not expressed. Leu-8 is found on unstimulated T cells but is only weakly expressed by T cells from secondary lymphoid organs [11] . Clonal LGL expansions were all Leu-8 -, again compatible with a phenotype of activated cells. Increased expression of CD69, an early or inducible activation marker [12] , distinguished clonal LGL expansions from the non-clonal expansions. It is unusual to observe co-expression of an early marker of recent activation, such as CD69, in conjunction with markers of late activation, although this has been reported for RA synovial fluid cells [13] .
The expression of these adhesion molecules and of HLA-DR is, therefore, in keeping with the original hypothesis that these expansions are chronically activated cells. The CD45R isoform expression is more difficult to interpret according to the above scheme. This scheme may, however, be more complex in CD8 T cells in that high levels of LFA-1, an adhesion molecule that is upregulated following T-cell activation, have been shown to be expressed on the surface of a proportion of CD45RA + , RO-, CD8+ T cells [14] . This expression increased with age, ranging from 8% in a 14 yr old to 94% in a 79 yr old [14] . Furthermore, in vitro studies have demonstrated reversal of CD45 isoform expression from CD45RO to CD45RA in long-term CD8 T-cell lines [15] comparable to data from CD4 cells [16] . Hence, CD45R isoform expression may not distinguish 'memory' from 'naive' T-cell populations in all circumstances and the CD45R phenotype of the T-cell LGL expansions in FS may still be compatible with the hypothesis of an antigen-driven process.
In normal individuals, increased numbers of CD8 -I-, CD57+ T cells have been shown to correlate with previous exposure to cytomegalovirus [17] . In that study (see also reference [2] ), over 40% of those cells co-expressed CD45RA and CD45RO (as did patient 9 in this study) and had suppressive properties [17] . In RA patients, CD3+ CD57+ T cells have been shown to have the phenotype CD45RA + , HLA-DR-, CD25-, i.e. of conventionally 'naive' T cells [18] . In the current study, a proportion of CD8 T cells from the peripheral blood of four RA patients showed evidence for activation in terms of CD45R isoform and HLA-DR expression. All were LFA-1+ , compatible with data from reference [14] discussed above. These activation phenotypes differ from that of the clonal expansions among the FS patients. Nevertheless, the possibility that cytomegalovirus or a related virus could be involved in driving these expansions remains an obvious hypothesis. Whether a similar or different antigen could be involved in driving T-cell LGL expansions in patients without RA has not yet been directly addressed, although from the limited data in this study the activation phenotype was similar.
It has been shown in both acute and chronic leukaemias that CD45RA+ expression is common, while CD45RO expression is more variable, with uncoupling of the normal relationships between these isoforms and activation markers, as seen in this study [19, 20] . A transformed phenotype may thus be more likely to express CD45RA and may not reflect the normal differentiation status of untransformed cells. The finding that the seven FS patients with clonal expansions had a uniform phenotype, while the three RA patients with LGL expansions that were nonclonal by RFLP analysis had more variable results, as well as our previous work [21] , support this proposal. Such a transformation event could still occur on a background of chronic antigenic stimulation [21] . A third possibility is that this unusual phenotype represents the activation of cells in a non-antigenspecific manner through ligands other than the T-cell receptor. T-cell activation by this mechanism has been proposed to occur in RA [13] .
Evidence exists for a selective increase in CD8 + CD57+ morphologic LGLs in RA synovial fluid [22] . This raises the issue of whether these cells are locally involved in the disease process. Only one of our patients had an effusion during the period of the study. This patient had an identifiable population of expanded V/?5.3+ LGLs in the peripheral blood, but also differed from the others in that the expansion was CD45RA-, CD45RO + . It was clear that the expanded population was not seen in the synovial fluid. One previous report describes a patient with a peripheral blood CD8 + V/?3 expansion that was also not found in synovial fluid or synovial tissue [23] . If these results are confirmed when data from more patients become available, it suggests that if LGLs are pathogenic in RA/FS, they exert their effects systemically, perhaps due to the effects of secreted cytokines.
